Clinical Trial

A Study of HS-20136-2 in Healthy Participants

Name: A Study of HS-20136-2 in Healthy Participants — clinical trial record (NCT07483437)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a randomized, double-blind,placebo-controlled phase I clinical study.The main purpose is to assess the safety and tolerability of single subcutaneous administration of HS-20136-2 injection in healthy participants.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-03-16.

Trial Details

NCT Number	NCT07483437
Lead Sponsor	Jiangsu Hansoh Pharmaceutical Co., Ltd.
Conditions	Healthy
Enrollment	38 participants
Start Date	2026-05-15
Primary Completion	2026-12-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-01